The European Medicines Agency (EMA) intends to speed up its regulatory procedures with an aim to grant marketing authorisations of safe and high-quality Covid-19 related medicines at the earliest. For this purpose, the Agency has shared an outline of its strategic plan.

The global in vitro diagnostics company EKF Diagnostics has signed a three-year distribution agreement with Tosoh Europe for the distribution of its Quo-Test HbA1c point-of-care (POC) analyzer in the Middle East and Africa.

Biotalys conducted a global fruit and vegetables field trial programme with its innovative biofungicide Biofun-1. The new protein-based biocontrol solution enables farmers to protect their yields and extend post-harvest protection with sustainable products.

Robert Darrington has been appointed Vice President of Research & Development at SP Industries. Darrington was originally tapped to lead the department as well as serve on the SP Executive Leadership Team in an interim role in October of 2019.

Researchers at Osaka University have developed a new catalytic system for efficiently splitting water and making hydrogen with energy from normal sunlight. Their study was recently reported in Angewandte Chemie International Edition.

Electronic devices are becoming continually smaller, more flat and multifunctional and their “inner life”, the microelectronic systems, along with them – thanks to 3D integration.

Physicians from Karl Landsteiner University of Health Sciences in Krems, Austria, presented results of the world's most extensive study investigating the value of 5-aminolevulinic acid in surgery of brain metastases.

Due to Covid-19, global demand for drugs and vaccines is growing rapidly. In response, manufacturers of biologics, sterile injectables, vaccines and cell and gene therapies are increasingly turning to the Growth Direct platform offered by Rapid Micro Systems.

In order to advance the development of their nanopore sequencer, Roche has acquired Stratos Genomics, an early-stage sequencing technology company.

Researchers have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable analyzer they have developed to conduct rapid on-site bio tests. If a suitable reagent is developed, this technology could be used to detect antibodies against Sars-Cov-2, the causative virus of Covid-19.